These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 28194512)
1. Should all patients with sepsis receive anticoagulation? Yes. Meziani F; Gando S; Vincent JL Intensive Care Med; 2017 Mar; 43(3):452-454. PubMed ID: 28194512 [No Abstract] [Full Text] [Related]
2. Should all septic patients be given systemic anticoagulation? No. van der Poll T; Opal SM Intensive Care Med; 2017 Mar; 43(3):455-457. PubMed ID: 28194511 [No Abstract] [Full Text] [Related]
3. [The first, second and third generations of treatments for disseminated intravascular coagulation (DIC)]. Wada H; Takemitsu S Rinsho Byori; 2011 Feb; Suppl 147():131-5. PubMed ID: 21761761 [No Abstract] [Full Text] [Related]
4. Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model. Schiffer ER; Reber G; De Moerloose P; Morel DR Crit Care Med; 2002 Dec; 30(12):2689-99. PubMed ID: 12483060 [TBL] [Abstract][Full Text] [Related]
5. [What is safe in the drug therapy of infection?]. Spilker D; Seiter A Beitr Infusionther Klin Ernahr; 1983; 10():196-203. PubMed ID: 6360142 [No Abstract] [Full Text] [Related]
6. The role of heparin and allied compounds in the treatment of sepsis. Cornet AD; Smit EG; Beishuizen A; Groeneveld AB Thromb Haemost; 2007 Sep; 98(3):579-86. PubMed ID: 17849046 [TBL] [Abstract][Full Text] [Related]
7. [Severe sepsis and septic shock: crossroad between inflammation and coagulation]. Jiménez Ortiz JL; Labarta Monzón L; Armengol Sáez S Med Clin (Barc); 2002 Jan; 118(2):78. PubMed ID: 11809155 [No Abstract] [Full Text] [Related]
8. [Severe sepsis and septic shock: crossroad between inflammation and coagulation]. Torrabadella De Reynoso P Med Clin (Barc); 2002 Apr; 118(13):517-8. PubMed ID: 11975893 [No Abstract] [Full Text] [Related]
9. [Heparin therapy in bacterial shock and acute kidney failure]. Dobrovol'skiĭ VI; Makatsariia AD Sov Med; 1984; (6):90-3. PubMed ID: 6463755 [No Abstract] [Full Text] [Related]
11. [Current trends in anticoagulant and thrombolytic therapy of thrombosis]. Gavrilov OK; Rachinskaia NA; Kaveshnikova BF Sov Med; 1975 Sep; (9):53-9. PubMed ID: 781864 [No Abstract] [Full Text] [Related]
12. [Study on guidelines for the treatment of DIC]. Wada H Rinsho Ketsueki; 2007 May; 48(5):377-85. PubMed ID: 17571582 [No Abstract] [Full Text] [Related]
13. [Anti DIC therapy]. Yahata M; Sakamoto Y Nihon Rinsho; 2016 Feb; 74(2):257-61. PubMed ID: 26915249 [TBL] [Abstract][Full Text] [Related]
14. [The correction of intravascular microcoagulation of the blood]. Iena IaM Lik Sprava; 1996; (1-2):20-6. PubMed ID: 9005097 [No Abstract] [Full Text] [Related]
15. Japanese consensus for disseminated intravascular coagulation (DIC): is it a small world after all? Levi M Thromb Res; 2010 Jan; 125(1):4-5. PubMed ID: 19735937 [No Abstract] [Full Text] [Related]
16. Guidelines for thrombolytic therapy. Khan SS J Am Coll Cardiol; 1998 Aug; 32(2):550-1. PubMed ID: 9708491 [No Abstract] [Full Text] [Related]
17. Coagulation and sepsis: a winding road ahead. Levi M Crit Care Med; 2012 Sep; 40(9):2733-4. PubMed ID: 22903108 [No Abstract] [Full Text] [Related]
18. [Prevention and treatment of disseminated intravascular coagulopathy]. Montanini S; Crisafi C Minerva Anestesiol; 1980 Jul; 46(7):855-62. PubMed ID: 6165934 [No Abstract] [Full Text] [Related]